Intratumoral cDC1 delivery prior to milder chemotherapy demonstrated significant increases in T-cell infiltration in the tumor, specifically increased CD3+, CD4+, and CD8+ T-cells as well as B-cells, γδ T-cells, and NKT cells. This evidence concerns the gene CD8A and neoplasm.